Amoy Diagnostics Co Ltd
SZSE:300685
Amoy Diagnostics Co Ltd's latest stock split occurred on May 31, 2022
The company executed a 1-for-1 stock split, meaning that for every share held, investors received 1 new share.
Before the split, Amoy Diagnostics Co Ltd traded at 47.8201 per share. Afterward, the share price was about 27.9014.
The adjusted shares began trading on May 31, 2022. This was Amoy Diagnostics Co Ltd's 3rd stock split, following the previous one in Jun 16, 2020.
1S9
Amoy Diagnostics Co Ltd
Glance View
Amoy Diagnostics Co., Ltd., nestled in the bustling city of Xiamen, China, has carved out a niche in the world of molecular diagnostics. Founded in 2008, the company has quickly become a pioneer in precision medicine, focusing on the development and commercialization of technologies for the detection of genetic mutations. At the heart of its operation lies its proprietary ADx-ARMS technology, an innovative method allowing for the precise and sensitive detection of mutations in tumor tissues and blood, facilitating oncology diagnostics. This technology not only empowers oncologists with critical insights for tailored cancer treatments but underscores Amoy Diagnostics' commitment to transforming patient care through cutting-edge genetic testing. The commercial prowess of Amoy Diagnostics is, however, much more than its technological innovations. The company thrives on a robust business model that hinges on a symbiotic relationship with the pharmaceutical industry and healthcare providers. By offering diagnostic services and research kits, Amoy Diagnostics provides crucial support in the development of targeted therapies, enabling pharmaceutical companies to test and bring to market personalized medicine solutions. Their revenue stream is bolstered by strategic partnerships and licensing agreements, which allow them to expand their portfolio and market reach both domestically and internationally. This dynamic approach not only ensures a wide adoption of their diagnostic solutions but also firmly positions Amoy Diagnostics as a key player in the rapidly growing field of precision oncology.
You don't have any saved screeners yet